학술논문
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial
Document Type
Article
Author
Source
In: Journal of the American Heart Association . (Journal of the American Heart Association, 16 April 2024, 13(8):e032782)
Subject
Language
English
ISSN
20479980